Synapse - Naiyer Rizvi

Search Within

Naiyer A Rizvi

Results (166)

Phase I study of obatoclax mesylate (GX15-070MS), a Bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors

Meeting Abstract

Brown, A. B.; Rudin, C.; Rizvi, N.; Travis, W.; Takebe, N.; James, L. P.; Subzwari, S.; Tyson, L.; Markus, S.; Krug, L. M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A pilot study comparing computerized volume measurement with diameter measurement as an early biomarker of the biologic activity of EGFR targeted therapy

Meeting Abstract

Zhao, B. S.; Oxnard, G. R.; Guo, P. Z.; Rizvi, N. A.; Kris, M. G.; Schwartz, L. H.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Meeting Abstract

Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: Results from a two-part, double-blind, randomized phase II study

Journal Article

Natale, R. B.; Bodkin, D.; Govindan, R.; Sleckman, B. G.; Rizvi, N. A.; Capo, A.; Germonpre, P.; Eberhardt, W. E. E.; Stockman, P. K.; Kennedy, S. J.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II trial of induction and adjuvant bevacizumab with cisplatin and docetaxel in patients with locally advanced NSCLC

Meeting Abstract

Kris, M. G.; Price, K. A.; Rusch, V. W.; Zhao, B. S.; Schwartz, L. H.; Guo, P. Z.; Tan, Y. Q.; Subzwari, S.; Finley, D.; Rizvi, N. A.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)

Meeting Abstract

Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer

Journal Article

Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients

Journal Article

Cassileth, B. R.; Rizvi, N.; Deng, G.; Yeung, K. S.; Vickers, A.; Guillen, S.; Woo, D.; Coleton, M.; Kris, M. G.
Cancer Chemotherapy and Pharmacology (2009)

Fulltext@MSK | Save

Assessing changes in tumor size with CT scans in lung cancer: Are volumetric measurements better than unidimensional (1D) and bidimensional (2D) assessments?

Meeting Abstract

Pietanza, M.; James, L. P.; Schwartz, L. H.; Ginsberg, M. S.; Zhao, B.; Moskowitz, C. S.; Zheng, J.; Rizvi, N. A.; Kris, M. G.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

WNK1 haplotypes and bevacizumab-induced hypertension

Meeting Abstract

Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J. A.; Rizvi, N. A.; Barakat, R. R.; Dickler, M. N.; Levine, D. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save